Zamansky LLC Investigates Platinum Partners Value Arbitrage Fund

The law firm is investigating the Platinum Partners Value Arbitrage Fund (“Platinum”) over its decision to close, and reported losses suffered  in Echo Therapeutics.   Platinum’s founder Murray Huberfeld was arrested June 8, 2016, and charged with allegedly paying a $60,000 “kickback” to Norman Seabrook, President of the NYC Corrections Officers Benevolent Association, in exchange for …

Zamansky LLC Investigates Hedge Funds With Large Valeant Stock Losses

The law firm is investigating various hedge funds which suffered large losses from investing in Valeant Pharmaceutical International Inc. (“Valeant”) stock.   According to public reports, these hedge funds include Pershing Square Capital Management, ValueAct Holdings, Brahman Capital, Brave Warriors Advisors, Okumus Capital and Senzar Asset Management have suffered large losses from investments in Valeant stock. …

Zamansky LLC Investigates Strategic Return Notes Sold to Merrill Lynch Brokerage Customers

Zamansky LLC is investigating claims for investors to recover losses suffered by Merrill Lynch brokerage customers who purchased Strategic Return Notes (“SRNs”).  In 2010, Merrill Lynch and Bank of America created the Strategic Return Notes which are notes with a maturity which do not pay interest but repay investors a variable amount based upon the …

Zamansky LLC Investigates the Shut-down of the Oppenheimer Commodities Strategy Total Return Fund

We are investigating the Oppenheimer Commodities Strategy Total Return Fund (the “Fund”) (QRAAX, QRANX, QRACX, QRABS, QRAYX and QRAIX) over the recent shut-down of this two-decade-old fund.  The Fund has suffered losses of approximately 27% in 2015, and 22% in 2014, and has seen its assets fall from $250 million to below $100 million. This …

Zamansky LLC Investigates Theranos and CEO Elizabeth Holmes

Zamansky LLC is investigating the Theranos and its CEO Elizabeth Holmes over recent reports that health regulators have proposed barring her from the blood-testing business for two years due to problems at its California lab that were not corrected.   Theranos’ recent problems raise issues over whether the company or its officers breached duties owed to …

Confidential Consultation

View All Current Investigations